Inhibition of gliomagenesis and attenuation of mitotic transition by MIIP

P Ji1, S M Smith, Y Wang

  • 1Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Oncogene
|April 27, 2010
PubMed

Insights

The migration and invasion inhibitor protein (MIIP) suppresses glioma development by inhibiting cell growth and blocking tumor progression. MIIP also disrupts cell division, leading to increased cancer cell death.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The migration and invasion inhibitor protein (MIIP) is a known negative regulator of cell migration and invasion.
  • Reduced MIIP expression is observed in glioblastoma patient samples, suggesting a potential role in gliomagenesis.
  • The specific function of MIIP in glioma development remains largely unknown.

Purpose of the Study:

  • To investigate the role of MIIP in gliomagenesis and its impact on mitotic transition.
  • To elucidate the molecular mechanisms by which MIIP affects glioma progression.

Main Methods:

  • In vitro studies using glioma cell lines to assess the effects of MIIP expression on cell growth and colony formation.
  • In vivo studies using a glial-specific mouse model to evaluate MIIP's role in glioma development.
  • Biochemical analyses to determine MIIP's interaction with cell cycle regulators, including Cdc20 and the anaphase-promoting complex (APC/C).

Main Results:

  • Increased MIIP expression inhibited glioma cell growth and colony formation in vitro.
  • Knockdown of MIIP using small interfering RNA led to increased glioma cell proliferation.
  • MIIP expression in a mouse model blocked glioma development and progression.
  • MIIP was found to attenuate mitotic transition, leading to increased mitotic catastrophe.
  • MIIP directly interacts with Cdc20, inhibiting APC/C-mediated degradation of cyclin B1.

Conclusions:

  • MIIP acts as a crucial inhibitor of gliomagenesis and progression.
  • MIIP's mechanism involves the attenuation of mitotic transition through regulation of APC/C activity via Cdc20 interaction.
  • MIIP's ability to induce mitotic catastrophe presents a potential therapeutic target for glioma treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...